³»¿ë |
´ÙÀ½°ú °°ÀÌ ÃÊû¼¼¹Ì³ª(WebEx °ÀÇ)°¡ ÀÖÀ¸´Ï ±³½Ç ±¸¼º¿ø ¿©·¯ºÐµéÀÇ ¸¹Àº Âü¼® ¹Ù¶ø´Ï´Ù.
1.¿¬ Á¦ : Development of Rivoceranib in combination with Camrelizumab for the treatment of unresectable Hepatocellular Carcinoma
2.¿¬ ÀÚ : Àå¼ºÈÆ ¹Ú»ç (Elevar Therapeutics)
3.ÀÏ ½Ã : 2024³â 04¿ù 19ÀÏ(±Ý) 16:00~ [Webex¹ÌÆÃ µ¿½ÃÁøÇà]
4.Àå ¼Ò : Àǰú´ëÇÐ 6Ãþ ¾à¹°À¯Àüü¿¬±¸¼¾ÅÍ ¼¼¹Ì³ª½Ç |
|